Oxford vaccine trial

Trials will have ups and downs, say scientists

Adverse effects were noted on two human subjects who volunteered for the phase 3 trials of AstraZeneca COVID-19 vaccine

Serum Institute of India: India will go ahead with Oxford COVID vaccine trials

The SII has been issued a show cause notice by Indian drug controller DCGI after one volunteer reported unwell in UK

Phase-2 human trial of the Oxford COVID-19 vaccine candidate begins in India

The phase-2 trial will be conducted on 100 volunteers at some sites across the country.

COVID case fatality rate in India on a steady decline, drops to 2.46 pc

In India, AIIMS began Phase 1 of human trials of COVID-19 vaccines on Monday, results of which are expected in three months

1 of 1